A trial to learn if AZD9829 is safe and works alone and in combination with other treatments for participants with certain blood cancers.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506997-11-00

Acronym

D9470C00001

Enrollment

Registered

2024-05-07

Start date

2024-10-09

Completion date

Unknown

Last updated

2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CD123-Positive Hematological Malignancies: Module 1 focuses on R/R Acute Myeloid Leukemia and R/R Myelodysplastic Syndrome.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026